American College of Rheumatology Annual Meeting

American College of Rheumatology Annual Meeting

December 06, 2016
2 min watch

VIDEO: Saag discusses lesinurad allopurinol extension trials

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

WASHINGTON — At the American College of Rheumatology Annual Meeting, Kenneth G. Saag, MD, professor of medicine in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham, discussed the CLEAR 1 and 2 extension studies of lesinurad and allopurinol combination therapy in patients with gout.

He mentioned the extension data were similar to those of the original study, which demonstrated good efficacy and safety. However, there was a slight rise in serum creatinine levels for some patients.